Sign In
Buy VIR
$8.77
+0.0300 (+0.343%)
At Close: Jun 03, 2026
Vir Biotechnology: A 'Magic Formula' Top Performer
05:30pm, Thursday, 22'nd Dec 2022
Joel Greenblatt (Trades, Portfolio), the manager of Gotham Capital, has what he calls a “Magic Formula” for investing. First detailed in "The Little Book That Beats the Market," this formula is ba
Vir Biotechnology: Collaborative Approach To Taking On Serious Diseases
08:44am, Saturday, 17'th Dec 2022
Vir Biotechnology is currently profitable with record breaking revenues, but performance is linked to unsustainable COVID-fueled sales results. Although sales are predicted to decline in 2023, the com
2 Fast-Growing Healthcare Stocks to Buy and Hold
07:10am, Friday, 02'nd Dec 2022
The innovative companies have made great gains in a short period of time.
Should Value Investors Buy Vir Biotechnology (VIR) Stock?
11:17am, Tuesday, 22'nd Nov 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
5 Winning Stocks Backed by the Overlooked Rising P/E Trick
09:02am, Monday, 21'st Nov 2022
Want to try an out-of-the-box approach? Tap AMC Entertainment (AMC), Live Nation Entertainment (LYV), CuriosityStream (CURI), Helius Medical Technologies (HSDT) and Vir Biotechnology (VIR).
VIR Biotech CEO on its positive Covid antibody drug results
09:36am, Saturday, 19'th Nov 2022
CNBC's Meg Tirrell discusses VIR Biotechnology's antibody drug results and what it can do to aid the Covid pandemic with VIR Biotech CEO George Scangos.
Wall Street Analysts Predict a 107% Upside in Vir Biotechnology, Inc. (VIR): Here's What You Should Know
02:55pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 107.4% in Vir Biotechnology, Inc. (VIR). While the effectiveness of this highly sought-after metric is question
Are Investors Undervaluing Dynavax Technologies (DVAX) Right Now?
02:40pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
08:07am, Monday, 07'th Nov 2022 Benzinga
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) shares surged 105.8% to close at $7.82 on Friday. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Lade
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection
03:35pm, Sunday, 06'th Nov 2022 GlobeNewswire Inc.
– Data from multiple ongoing trials evaluating Vir’s two novel HBV therapies continue to demonstrate substantial reductions in hepatitis B surface antigen (HBsAg) with no new safety signals –
Why Vir Biotechnology Jumped Nearly 19% Today
08:16pm, Friday, 04'th Nov 2022 The Motley Fool
A COVID-19 partnership with a major drugmaker is producing more fruit than expected.
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
04:54pm, Friday, 04'th Nov 2022 Benzinga
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) jumped 115% to $8.17. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Ladenburg Thalmann initiated cov
What 5 Analyst Ratings Have To Say About Vir Biotechnology
04:29pm, Friday, 04'th Nov 2022 Benzinga
Over the past 3 months, 5 analysts have published their opinion on Vir Biotechnology (NASDAQ:VIR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding
Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday
03:26pm, Friday, 04'th Nov 2022 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Willdan Group, Inc. (NASDAQ: WLDN) surged 27.6% to
Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth
11:34am, Friday, 04'th Nov 2022
Vir Biotechnology obliterated expectations for its Covid drug in the third quarter, and Vir stock leaped above its 200-day line. The post Vir Obliterates Quarterly Sales Expectations As Covid Drug Del
